JBS N.V. Class A Common Shares vs Oscar Health Inc — how do they compare? JBS N.V. Class A Common Shares trades at $13.02 (market cap $13.96B), while Oscar Health Inc trades at $34.01 (market cap $10.59B). The key difference: JBS N.V. Class A Common Shares is the larger of the two by market cap, and JBS N.V. Class A Common Shares pays a 10.31% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold JBS N.V. Class A Common Shares for 0 Days and Oscar Health Inc for 15 Days on average.
| JBS | OSCR | |
|---|---|---|
Market Cap | $13.96B | $10.59B |
Volume | 5,326,589 | 5,280,571 |
Sector | Consumer Staples | Health |
52-Week High | $18.42 | $34.32 |
52-Week Low | $10.86 | $10.85 |
Typical Hold Time | 0 Days | 15 Days |
Enterprise Value | $34.93B | $6.95B |
Dividend Yield | 10.31% | — |
Signals from Pluang's Aura AI — not financial advice
JBS trades at $12.93, up 0.54% today, with a neutral technical signal and strong analyst buy consensus. The stock shows attractive valuation with a P/E of 12.08 and P/S of 0.47, though recent quarterly EPS misses and a declining profit margin to 1.22% in 2026 highlight earnings pressure. Recent news includes a proposal to acquire full control of Pilgrim's Pride and a joint venture in Southeast Asia, indicating strategic expansion.
The outlook is mixed: analyst targets suggest ~40% upside to $18.17, but risks include execution on acquisitions, margin compression, and volatile beef markets. Cash flow turned positive in 2026 projections, supporting growth initiatives, yet debt levels and competitive pressures warrant caution for investors seeking stability.
Oscar Health (OSCR) trades at $33.79, down 0.65% on the day, with strong technical momentum indicated by bullish moving averages and ADX signals. The company shows impressive revenue growth from $11.7B in 2025 to $15.3B projected for 2026, with profitability turning positive from a $443M loss to $551M net income. Recent earnings beats in Q1 and Q2 2026 exceeded expectations by significant margins, while analyst sentiment remains mixed with a $34.75 consensus target slightly above current levels.
OSCR presents a growth story with expanding market share in ACA plans and improved medical loss ratios, though profitability remains sensitive to medical cost trends. The stock faces near-term resistance at $35 with RSI suggesting potential overbought conditions. Key risks include execution on growth targets and healthcare cost pressures, while institutional interest remains strong with recent price target upgrades following positive guidance.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
JBS N.V. is a protein-processing company producing beef, pork, poultry, lamb, fish, and plant-based products, headquartered in São Paulo and Amsterdam. It operates more than 250 production facilities across over 16 countries under brands including Friboi, Seara, Swift, and Pilgrim's, and is the majority shareholder of Pilgrim's Pride Corporation.
Read more on JBS →Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →